Randal A Skidgel
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$3.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 30, 2025 | NIH | SBIR Phase I A new drug to treat transplant-associated renal ischemia-reperfusion injury | $307K | DUPAGE MEDICAL TECHNOLOGY, INC. |
| Aug 26, 2023 | NIH | SBIR Phase II Targeting integrin outside-in signaling for treating sepsis | $582K | DUPAGE MEDICAL TECHNOLOGY, INC. |
| Aug 18, 2022 | NIH | SBIR Phase II Developing a new drug for treating myocardial ischemia/reperfusion injury | $1.1M | DUPAGE MEDICAL TECHNOLOGY, INC. |
| May 20, 2022 | NIH | SBIR Phase II Targeting integrin outside-in signaling for treating sepsis | $635K | DUPAGE MEDICAL TECHNOLOGY, INC. |
| Aug 4, 2021 | NIH | SBIR Phase II Targeting integrin outside-in signaling for treating sepsis | $777K | DUPAGE MEDICAL TECHNOLOGY, INC. |
Peer ranks
Federal funding#502
Awards as PI#417
Patents#273
Companies
- DUPAGE MEDICAL TECHNOLOGY, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.